MetLife earnings beat by $0.03, revenue topped estimates

MetLife (MET) reported Q3 EPS of $2.78, beating estimates by $0.03, with revenue at $20.52B, exceeding expectations. The stock is up 5.24% over 3 months and 30.77% over 12 months. InvestingPro rates its financial health as 'good performance'.

Original reporting
Published Nov 4, 2026, 9:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 9:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MET
Bullish
high confidence
Mentioned
$MET
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$METBullishHigh
01

Why it matters

The beat may trigger short covering and new buying, especially from investors seeking exposure to stable insurers.

02

Market read

A large‑cap insurer's earnings beat can influence insurance sector sentiment and modestly lift broader market indices.

03

What to watch

Potential impact of upcoming regulatory changes or claim trends not discussed in the article.

Relevance 8/10Novelty 8/10Timing: after market close

Background

MetLife's Q3 earnings were released on November 4, 2026, showing modest beats on both earnings per share and revenue.

Company-level read

Ticker impact

$METBullishHigh confidence
Context

MetLife reported Q3 EPS $2.78, beating the $2.75 estimate, and revenue $20.52B versus $19.91B consensus.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

The beat exceeds expectations on both EPS and revenue for a large‑cap insurer, prompting buying interest.

Market effects

Insurance sector may see modest rally as a large player beats expectations.

U.S. equities could receive a small boost from the positive earnings news.

Limited to markets tracking U.S. insurers; no broad global effect.

Counterpoint

If guidance is weak or future outlook uncertain, the beat may be priced out quickly.

Key entities

  • MetLife

    Large U.S. insurer reporting Q3 results.

Related articles

$METHighAI 8/10

MetLife Q3 Earnings Call Highlights

MetLife reported Q3 earnings, with variable investment income of $1.5B for the first nine months, on track to exceed its $1.6B full-year guidance. Group Benefits and Retirement adjusted earnings rose 14% and 12% respectively. International operations saw mixed results, with Asia up 21% and Latin America down 5%. The company repurchased $650M in shares in Q3 and is on track to meet its full-year targets.

$METMedAI 8/10

Chesnara bags £1.7bn MetLife UK closed life book in latest takeover

Chesnara agreed to acquire MetLife UK's closed-book life insurance business for £1.7bn in assets, subject to regulatory approval. The deal is expected to generate £90m in lifetime cashflows, with £45m added to Own Funds and Contractual Service Margin. Chesnara aims to strengthen its UK business and future cash generation. Analysts note the deal boosts long-term capital generation without significantly impacting Chesnara's acquisition firepower.

$METMed

Chesnara To Buy MetLife's Closed-book UK Life Insurance Firm; Terms Not Disclosed

Chesnara plc (CSN.L) agreed to buy MetLife's (MET) closed-book UK life insurance unit, MetLife UK Limited, for an undisclosed sum. The deal, expected to close in early 2027, will add 18,000 policies and £1.7 billion in assets. Chesnara anticipates £45 million boost to Own Funds and Contractual Service Margin, with £90 million in lifetime cash flows, half within five years. Shares rose 1.15%.

$METHighAI 9/10

MetLife (MET) Q3 2026 Earnings Call Transcript

MetLife (MET) reported Q3 2026 adjusted earnings of $1.8B ($2.85 EPS), up 17% YoY. Adjusted EPS ex-items rose 22%, with ROE at 19.6%. Growth was driven by Group Benefits, Retirement & Income Solutions, and Asia. The company repurchased $650M in shares, bringing YTD capital return to $3.5B.